Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 5,112 | 2,458 | 5,809 | 181 | 6,371 |
| Cost of Goods | 1,889 | 2,293 | 1,376 | 384 | 1,680 |
| Gross Profit | 3,223 | 165 | 4,433 | -203 | 4,691 |
| Operating Expenses | 7,664 | 7,794 | 8,388 | 12,233 | 24,095 |
| Operating Income | -3,552 | -7,336 | -3,579 | -12,052 | -18,724 |
| Other Income | 69,568 | -1,219 | 1,228 | 3,724 | 108,243 |
| Pre-tax Income | 66,016 | -8,555 | -2,351 | -8,328 | 89,519 |
| Income Tax | 11 | 3 | 3 | 14 | 13 |
| Net Income Continuous | 66,005 | -8,558 | -2,354 | -8,342 | 89,506 |
| Net Income | $66,005 | $-8,558 | $-2,354 | $-8,336 | $89,506 |
| EPS Basic Total Ops | 15.34 | -5.43 | -1.85 | 637.59 | 135.72 |
| EPS Basic Continuous Ops | 15.58 | -5.43 | -1.85 | 639.43 | 135.72 |
| EPS Diluted Total Ops | 0.10 | -5.43 | -1.85 | 777.70 | -4.39 |
| EPS Diluted Continuous Ops | 0.09 | -5.43 | -1.85 | 755.00 | 20.15 |
| EBITDA(a) | $-3,464 | $-6,459 | $-2,830 | $-11,802 | $-18,474 |